Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04365855 · ClinicalTrials.gov registry record · NA

The Olmsted NAFLD Epidemiology Study (TONES)

A NA study of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT04365855 is a NA study of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 800 participants, above the 174-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (360% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04365855, a NA study of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults with NAFLD and NASH to validate models of NAFLD diagnosis and determine long-term outcomes.

Interventions

  • OTHER Blood draw
  • DIAGNOSTIC_TEST Magnetic Resonance Elastography
  • PROCEDURE Liver biopsy
  • PROCEDURE Fibro Scan

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2020-10-10
Est. Completion 2028-06
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04365855

The ClinicalTrials.gov registry entry for NCT04365855 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 174-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (360% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 4 interventions - of which Blood draw is the first listed.

NCT04365855 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04365855 about?

NCT04365855 is a clinical study titled "The Olmsted NAFLD Epidemiology Study (TONES)". Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults with NAFLD and NASH to validate models of NAFLD diagnosis and determine long-term outcomes.

What is the current status of trial NCT04365855?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2020-10-10. Estimated completion is 2028-06.

What conditions does trial NCT04365855 study?

This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis.

What interventions are being tested in trial NCT04365855?

The interventions under investigation include: Blood draw (OTHER), Magnetic Resonance Elastography (DIAGNOSTIC_TEST), Liver biopsy (PROCEDURE), Fibro Scan (PROCEDURE).

Who is sponsoring clinical trial NCT04365855?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04365855 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-alcoholic Fatty Liver Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.